Trade Mark Journal No.2026/003 16 January 2026

UK00004283363 24 October 2025 (40,42)

WuXi XIntegrated

Class 40: Custom assembling of materials for others; custom manufacturing of pharmaceuticals; custom manufacturing of drug conjugates; customized production service of pharmaceuticals; customized production service of biological preparations; custom manufacturing of antibody-drug conjugates; processing or treating of chemical reagents; pharmaceutical processing; processing of biomedical preparations; processing of drug conjugates; processing of antibody drugs; custom manufacturing of antibody drugs; processing of biotechnology drug.
Class 42: Development of products for others; drug development service; research and development of new products; biochemical research and development; custom design and development of chemical reagent antibodies and conjugate antibodies; research and development in the field of pharmaceutical biomedicine and biotechnology, especially the research of antibodies including conjugated antibodies; biomedical research service; development of pharmaceutical preparations and medicines; research and development of antibody-drug conjugates; research and development of drug conjugates; pre-clinical research and evaluation of new drugs; consulting services in the field of technology development; pharmaceutical research services; scientific research and development; research and development of antibodies.

WuXi XDC Cayman Inc.

Representative: Brand Murray Fuller LLP